Introduction
In 1929, when Drury and Szent-Györgyi made the seminal observation that extracellular purines exert powerful biological effects on the cardiovascular system, new vistas were opened for future research. However, it took another 40 years unless Geoffrey Burnstock described non-adrenergic, non-cholinergic responses of visceral organs to autonomic nerve stimulation and made the fascinating suggestion that extracellular adenosine triphosphate (ATP) may function as a transmitter substance (Burnstock et al. 1970; Burnstock 1972) . This hypothesis enormously fertilized purinergic research, and, especially after the discovery of the large family of nucleotide-sensitive P2 receptortypes, it led to the understanding that extracellular purines are involved in virtually all body functions (Ralevic and Burnstock 1998) . After the cloning of various P2 receptor types, it was found that the functional properties of recombinant receptors in many cases differ from those of their native counterparts (Khakh et al. 2001; Abbracchio et al. 2006) . The explanation of this riddle appears to be that P2X receptors can consist of heteromeric assemblies of different subunits or of homomeric assemblies of different splice variants of the same subunit, that P2Y receptors can occur as dimeric structures, that both P2X and P2Y receptors can physically associate with additional receptors, and finally that P2 receptors can interact with their intracellular signalling complexes as well as with other ion channels, transporters and cytoskeletal constituents, developing a pronounced tissue or organ specificity (see below).
Our group has been studying for many years the interaction between various receptors (α 2 adrenergic/opioid κ, Ramme et al. 1986 ; neuropeptide Y/α 2 , ; α 2 /opioid μ, ; neuropeptide Y/nicotinic acetlycholine (ACh), Nörenberg et al. 1991 Nörenberg et al. , 1995 ; N-methyl-D-aspartate (NMDA)/adenosine A 2A , Nörenberg et al. 1997; Wirkner et al. 2000 Wirkner et al. , 2004a both at the terminals of postganglionicsympathetic nerves and at the cell somata of central noradrenergic and GABAergic neurons. More recently, it appeared only logical to continue these investigations by elucidating the cross-talk between P2Y receptors with a series of voltage-or ligand-gated ion channels Gerevich et al. , 2007 Wirkner et al. 2004b Wirkner et al. , 2007 . Therefore, as an extension of our experimental work, we decided to summarize the present knowledge on the interactions between P2 purinergic receptors and various other macromolecules in this review. We believe that the better understanding of these cross-talks will clarify many unresolved questions and, in consequence, contribute to the integration and utilization of the enormous knowledge accumulated in the purine research area.
Cloned purinergic receptors
The P2 purinergic receptors have been divided into two types: ATP-gated ion channels (P2X) and G proteincoupled receptors (P2Y; Burnstock and Kennedy 1985) . Seven different P2X subunits (P2X [1] [2] [3] [4] [5] [6] [7] ) and eight distinct P2Y subunits (P2Y 1, 2, 4, 6, [11] [12] [13] [14] have been cloned to date from mammalian cells. However, the receptor diversity is most likely greater due to heteromeric/oligomeric assembly and alternate splicing of the subunits. The expression profile of P2 receptor subtypes varies depending on the cell type (North 2002; Ralevic and Burnstock 1998) . P2X receptors P2X receptor channels comprise the third and one of the simplest families of ligand-gated ion channels besides the Cys-loop and glutamate receptor families (North 1996) . The P2X subunit proteins are 379 (P2X 6 ) to 595 (P2X 7 ) amino acids long, possessing intracellular cytoplasmic N and C termini and two transmembrane (TM) domains connected by a large extracellular loop (Newbolt et al. 1998) . Three P2X receptor subunits assemble into an ATPactivated ion channel by forming a central pore North 2002; Ralevic and Burnstock 1998; Robertson et al. 2001) .
Of the subunits, the C-terminal domain is the leastconserved part in amino acid composition, ranging in length between 27 (P2X 6 ) and 239 (P2X 7 ) amino acids, indicating that it might confer subunit-specific properties. It contains several residues playing important roles, e.g. by determining the rate of desensitisation; it is also involved in receptor trafficking (Chaumont et al. 2004; Denlinger et al. 2003; North 2002; Royle et al. 2002) . C termini play a major role in direct physical interactions with Cys-loop receptors. Both N and C termini are targets for post-transcriptional modifications, RNA splicing, phosphorylation (for an opposite view, see Brown and Yule 2007) , and protein-protein interactions with other receptors or regulatory molecules (Boue-Grabot et al. 2003; Denlinger et al. 2001; Kim et al. 2001 ; Koshimizu et al. 2006; Royle et al. 2002; Wilson et al. 2002) . These modifications and interactions may have a critical influence on the channel function (Boue-Grabot et al. 2000; Smith et al. 1999; Royle et al. 2002) .
The ectodomains of adjacent subunits appear to form the ATP binding pocket and sites for antagonists and modulators (Marquez-Klaka et al. 2007 ). The ectodomain is glycosylated and contains ten conserved cysteine residues forming a series of disulfide bridges; hydrophobic regions close to the pore vestibule serve as sites for possible receptor/channel modulation by cations (Mg 2+ , Ca 2+ , Zn 2+ , Cu 2+ and H + ; Ennion and Evans 2002; North 2002; Rettinger et al. 2000) . Data from our laboratory indicate that putative phosphorylation of the ectodomain by ectoprotein kinase C (PKC) potentiates the P2X 3 receptor current (Wirkner et al. 2005) . The TM domains are involved in receptor heteromerization and might serve as binding sites for ivermectin in case of P2X 4 receptors (Jiang et al. 2003; Silberberg et al. 2007) .
Basic pharmacological and functional analysis of the homomeric P2X channels show that two subtypes, P2X 1 and P2X 3 , are rapidly desensitising and activated by α,β-methylene ATP (α,β-meATP) . Other subtypes are relatively insensitive to this agonist and show moderate (P2X 4 ) or slow (P2X 2 , P2X 5 , P2X 6 and P2X 7 ) desensitisation. ATP is a general, natural agonist at each P2X receptor type (although at P2X 7 only at high concentrations). The conventional P2 receptor antagonists, such as suramin and pyridoxal-phosphate-6-azophenyl-2″,4″-disulphonic acid (PPADS) are not subtype specific (although P2X 4 and P2X 7 receptors are relatively insensitive to these compounds), and they block several P2Y subtypes, similar to another classic antagonist, reactive blue 2 (Chizh and Illes 2001; Koles et al. 2007 ). For more details of P2X pharmacology, see recent comprehensive reviews (e.g. Gever et al. 2006 ).
P2Y receptors
P2Y receptors have an extracellular N terminus containing several potential glycosylation sites, seven TM domains, and an intracellular C terminus that contains several consensus binding/phosphorylation sites for protein kinases. Some positively charged residues in TM domains 3, 6 and 7 seem to be crucial for receptor activation by agonists Erb et al. 2006) .
The classification of the P2Y receptor subtypes can be based on their pharmacological profile or on their heterotrimeric G protein subtype-coupling preference. The simplified pharmacological classification differentiates between purine-selective receptors such as P2Y 1 [most potent agonists are adenosine diphosphate (ADP) and its analogues], P2Y 11 (ATP), P2Y 12 (ADP and its analogues), P2Y 13 (ADP and its analogues) and the pyrimidineselective receptors P2Y 4 [uridine triphosphate (UTP)], P2Y 6 [uridine diphosphate (UDP)] and P2Y 14 (UDPglucose). The P2Y 2 receptor is activated by both ATP and UTP with approximately equal potency. Because of this latter property, it is often characterized as belonging to the pyrimidine-sensitive subgroup. The classical antagonists show the following profile: suramin antagonizes most P2Y receptors but not P2Y 4 ; PPADS antagonizes with the highest potency P2Y 1 receptors and blocks the other P2Y receptors only weakly or not at all; reactive blue 2 is not effective as an antagonist at P2Y 2 receptors but more (P2Y 6 ) or less effectively antagonizes the other ones. For a more detailed pharmacological characterization of P2Y receptors, see recent reviews (von Kugelgen 2006) .
The classification of the P2Y receptors based on the G protein subtype preference is the following: P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 and P2Y 11 belong to the (pertussis-toxinresistant) G q -protein-coupled subfamily, while the (pertussis-toxin-sensitive) G i -coupled subfamily comprises P2Y 12 , P2Y 13 and P2Y 14 receptors Erb et al. 2006; Koles et al. 2005; Volonte et al. 2006) . However, the situation in reality is more complex. Individual P2Y receptors can couple to functionally distinct heterotrimeric G proteins, as well as to monomeric small GTPases (Erb et al. 2006) .
Receptor heteromerization
When the cloned receptors are expressed in heterologous expression systems (e.g. Xenopus laevis oocytes), their individual phenotype can be easily characterized. However, in most cases, the phenotypes observed in native tissues do not closely resemble those reported for the cloned subunits (North 2002; Ralevic and Burnstock 1998) . They may have a different pharmacological profile (e.g. selectivity of the ligands for the receptor), or functional properties (e.g. channel kinetics, coupling to signalling pathways). One of the possible explanations of this divergence is that various subunits can co-assemble to form a native channel with distinct functional properties. Indeed, both ionotropic receptors including the P2X channels as well as many G protein coupled receptors, including the P2Y receptors, have been reported to exist in oligomeric (homomeric or heteromeric) assemblies of more than one subunit (Burnstock 2007) .
Heteromeric assembly of P2X receptors Lewis et al. (1995) reported about a decade ago that P2X receptors are multimers. They showed that co-expression of P2X 2 and P2X 3 subunits in human embryonic kidney (HEK)293 cells provided a channel that is similar in its properties to that observed in rat nodose and dorsal root ganglia (DRG) cells likely due to heteropolymerization of the subunits. About 2 years later, a co-immunoprecipitation study directly demonstrated the association of the P2X 2 and P2X 3 subunits as a heteromeric assembly in the cell membrane (Radford et al. 1997) . The heteromeric channel shares with the homomeric P2X 3 receptor its pharmacological profile; however, it resembles the homomeric P2X 2 receptor in its slow desensitisation kinetics (Burnstock 2000; Chizh and Illes 2001) .
Further studies revealed that the most plausible structural arrangement of P2X receptors is a trimeric architecture (Nicke et al. 1998) . For instance, the P2X 2/3 heteromeric channel is most probably composed of one P2X 2 subunit and two P2X 3 subunits (Jiang et al. 2003) . Early coimmunoprecipitation assays indicated that the subunitsubunit interaction is dependent upon a motif(s) present in the second TM domain of the P2X receptor protein (Torres et al. 1999a) . The subunits of the homomeric P2X 2 channels have been suggested to be arranged in a head-totail manner in which contacts are made between the TM1 segment of one subunit and the TM2 segment of another subunit located in close physical proximity to each other in the cell membrane. The subunits of the homomeric P2X 4 channels and the heteromeric P2X 2/3 receptors are connected with each other in a similar manner (Jiang et al. 2003) . A recent study showed that although C-terminal splicing of P2X 2 receptors did not disturb homo-and heteropolymerization, there are inter-subunit interactions between the C-terminal cytoplasmic tails, as indicated by means of bioluminescence resonance energy transfer (BRET) analysis (Koshimizu et al. 2006) . Moreover, shortening the C termini by progressive splicing accelerated energy transfer efficiency between C tails of one subunit and C or N tails of another subunit. It was suggested that splicing could enhance cytoplasmic inter-subunit proteinprotein interactions in P2X 2 receptors; this may have consequences for the channel properties. Heteromeric P2X 2 channels were formed by any combination of the three P2X 2 splicing subunits found in the pituitary.
Following the demonstration of the existence of heteromeric P2X 2/3 channels, evidence for the heteromeric association of other P2X subunits was also provided. Central P2X 4 and P2X 6 channel subunits have been reported to co-assemble into P2X 4/6 heteromers in X. laevis oocytes. Co-expression of P2X 1 and P2X 5 subunits in HEK293 cells revealed a novel ATP-gated ion channel, the P2X 1/5 heteromer (Le et al. 1998; Torres et al. 1998) . In both cases, the heteromers exhibited unique pharmacological and functional properties. Furthermore, a comprehensive study using a co-immunoprecipitation assay demonstrated that six of the seven P2X subunits were able to form hetero-oligomeric assemblies in HEK293 cells, the exception being P2X 7 . Whereas P2X 1 , P2X 2 , P2X 5 and P2X 6 were able to assemble with most subunits, P2X 3 and P2X 4 exhibited a more restricted pattern of co-association (Torres et al. 1999b ). Subsequently, the existence of functional P2X 2/6 (King et al. 2000) , P2X 1/2 and, more recently, P2X 1/4 (Nicke et al. 2005) heteromeric receptors have been identified. In most cases, the heteromeric P2X receptors showed a pharmacological and functional profile distinct from that of the cloned homomeric P2X receptors, often explaining the discrepancies and filling the gap between the properties of the cloned and the native P2X receptors. Thus, the elucidation of protein-protein interactions between various P2X subunits can considerably contribute to the better understanding of the purinergic signalling. Nevertheless, further efforts are needed to clarify the P2X subunit heteromerization and its (patho)physiological importance. A number of questions have to be answered for this purpose. For instance, are there further heteromeric phenotypes in addition to the presently known ones? Can only two different subunits co-assemble to form a heteromer, or three different subunits could also be involved in a trimeric assembly, as it was suggested for various P2X 2 splice variants (Koshimizu et al. 2006) ? If the P2X 6 subunits do not interact with each other to constitute homomers (Torres et al. 1999b) , how can they interact with other P2X subunits to form heteromeric channels? Is this mysterious P2X 6 receptor subunit merely a regulatory protein of the heteromeric cation channels?
Recent studies provided answers to some of these questions. Immunocytochemistry combined with surface biotinylation and atomic force microscopy identified an uncharged region within the N terminus of the P2X 6 subunit as the main determinant, inhibiting its assembly and exit from the endoplasmatic reticulum (14 amino acids immediately after the first methionine, especially serine residues at positions 3 and 11; Bobanovic et al. 2002; Ormond et al. 2006) . The P2X 2 and P2X 4 subunits, when they heteromerize with the P2X 6 subunit, either mask the N terminus of the P2X 6 or overcome its inhibitory effect by actively promoting the assembly process. The P2X 6 subunit may increase the calcium permeability of the P2X 2 pore (Egan and Khakh 2004) . The subunit stoichiometry of P2X 2/6 heteromers has been reported to be plastic and dependent on the relative subunit expression levels. Since the P2X 6 subunit is up-regulated under pathological conditions (Banfi et al. 2005) , this kind of plasticity of receptor stoichiometry may have functional consequences. In general, this property of receptor assembly might open an additional path and level in the research on the P2X receptor (patho)physiology (Barrera et al. 2007 ).
For some time, the P2X 7 subunit was postulated not to be involved in receptor heteromerization (Torres et al. 1999b) . However, more recently, convincing evidence has been presented for functional heteromeric P2X 4/7 receptors (Guo et al. 2007 ). Moreover, in tumor cells, a truncated naturally occurring splice variant of the human P2X 7 receptor was identified, which is unable to form pores and fails to mediate apoptosis in response to agonist stimulation (Feng et al. 2006 ). This truncated variant has been suggested to interact (hetero-oligomerize) with the fulllength counterpart abrogating its apoptotic ability. Since most proteins have splice variants, the possibility of such a hetero-oligomerization between a dominant negative truncated subunit and its full-length counterpart may raise additional questions regarding the role of hetero-oligomerization in the purinergic system.
Oligomeric assembly of P2Y receptors
The conventional idea until the 1990s was that a G proteincoupled receptor (GPCR) is a monomeric transmembrane protein which, upon ligand binding, interacts with a heterotrimeric G protein and, in consequence, initiates the events characteristic for receptor activation. However, this view was revised, as a growing body of biochemical and biophysical evidence indicated that GPCRs exist as oligomeric complexes (Bouvier 2001) . Interestingly, the first study indicating that a P2Y receptor may constitute such an oligomeric complex demonstrated the association of P2Y subunits with receptors from other GPCR families. Namely, the A 1 adenosine and the P2Y 1 nucleotide receptor have been reported to co-immunoprecipitate in HEK293 cells (Yoshioka et al. 2001) . Surprisingly, this hybrid receptor had P2Y 1 -like agonist selectivity but a preferential signalling pathway characteristic for the A 1 receptors. Hence, the P2Y agonist ADP-β-S has been reported to interact with the ligand-binding pocket of the heteromer, initiating events (coupling to G i/o proteins) which are characteristic for the A 1 activation. The hetero-oligomerization of these GPCRs was confirmed by BRET technology as well (Yoshioka et al. 2002a ). The high degree of colocalization and direct association of P2Y 1 and A 1 receptors was also shown in rat brain tissue. Moreover, agonistdependent changes have been reported in the heteromeric association of the receptors, i.e. combination of the respective agonists further promoted hetero-oligomerization of A 1 and P2Y 1 receptors (Yoshioka et al. 2002b) . A recent study with postembedding immunogold electron microscopy revealed that A 1 and P2Y 1 receptors are co-localized at the synaptic membranes and surrounding astroglial membranes of glutamatergic synapses (Tonazzini et al. 2007 ). P2Y 1 receptor stimulation impaired the potency of A 1 receptor-coupling to a G protein, whereas the stimulation of A 1 receptors increased the functional responsiveness of P2Y 1 receptors.
Direct association between A 1 receptors and P2Y 2 receptors was also demonstrated by co-immunoprecipitation, confocal immunofluorescence and immunoelectron microscopy in HEK293 cells (Suzuki et al. 2006 ). The simultaneous application of A 1 and P2Y 2 receptor agonists attenuated the functional activity of the A 1 receptors (G i/o mediated inhibition of adenylate cyclase) but enhanced signalling (via G q/11 -protein) characteristic for P2Y 2 activation.
If the P2Y receptor subtypes can form oligomeric complexes with other GPCRs, why would they not form homomers with each other or heteromers with other members of the P2Y receptor family? From this point of view, it is not surprising that a fluorescence resonance energy transfer (FRET) analysis demonstrated the existence of homo-oligomeric complexes of P2Y 2 subunits in the heterologous expression systems, HEK293, and K562 human erythroleukemia cells (Kotevic et al. 2005) . Western blotting of the P2Y 1 subtype in smooth muscle cells and endothelial cells suggested that the P2Y 1 receptor needs to be oligomerized to be active (Wang et al. 2002) . The P2Y 4 subunit has been recently reported to be able to form dimeric complexes . These dimers were partially resistant to denaturing and reducing conditions, indicating that they derive, at least in part, from covalent disulphide bonds occurring between the subunits. Moreover, both rat and human endogenous P2Y 4 receptors and heterologous P2Y 4 receptors transiently transfected in the neuroblastoma SH-SY5Y cell line appeared as stable dimers. A subsequent study revealed a novel molecular complexity and dynamic architecture of P2Y 4 and P2Y 6 proteins (D'Ambrosi et al. 2007 ). Namely, the P2Y 4 receptor is mostly expressed as a macromolecular complex disaggregated to a dimeric form by low detergent concentration. The higher-order complexes comprise P2Y 4 (dimeric) and P2Y 6 (monomeric) receptors in native neuronal phenotypes. The monomeric/dimeric protomers are differently distributed in specialized membrane microdomains, and the homo-and hetero-oligomeric complexes are differently modulated by ligand activation.
A recent immunoblotting analysis showed that native P2Y 12 receptors in freshly isolated platelets and recombinant P2Y 12 receptors heterologously expressed in HEK293 cells predominantly exist as homo-oligomers situated in lipid rafts (Savi et al. 2006) . Furthermore, this state is essential for their functionality. An active metabolite of clopidogrel (an irreversible P2Y 12 antagonist) coupled through a disulfide bridge, presumably to the cysteine residue in the first extracellular loop of the P2Y 12 receptor, and dissociated the oligomers into dimeric entities that partitioned out of lipid rafts. This led to the loss of their ability to bind their endogenous ligands. P2Y 1 and P2Y 11 receptors were found to associate physically when co-expressed in HEK293 cells (Ecke et al. 2007 ). This association was detected by co-pulldown, immunoprecipitation and FRET experiments, and promoted agonist-induced internalization of the P2Y 11 receptor, which by itself was completely endocytosis-reluctant. The agonist profile of P2Y 11 receptors also changed upon coexpression with P2Y 1 receptors.
The homo-and hetero-oligomerization of the P2Y receptor subtypes with each other or with the adenosine receptors diversify the agonist and antagonist selectivity, signalling and functional properties of the purinergic GPCRs and may explain some unexpected data obtained from experiments in native preparations (Volonte et al. 2006) . This issue, together with several other kinds of molecular complexities and diversities among P2 receptor subunits, led to the combinatorial receptor web concept of the P2 receptors. P2 proteins are considered not as separated entities but as dynamic and continuously changing and interacting cell constituents, and a combinatory calculation may allow the prediction of their complex dynamic architecture and sophisticated nature.
P2Y 2 receptor activation has been reported to inhibit β 2 adrenergic receptor-mediated cAMP generation in mouse pineal gland tumor cells (Suh et al. 2001 ). The exact mechanism was not clarified, but the authors suggested a close co-localization of P2Y 2 and β 2 receptors to explain the rapid and selective interaction, indicating that receptor heteromerization might exist not only between the members of the purinergic receptor family but also between the purinergic and other GPCRs.
Since P2Y 4 receptors have been reported to be colocalized at the membrane level with NMDAR1 receptors (Cavaliere et al. 2004) , and P2Y subunits are able to modulate the functions of various voltage-and/or ligandgated ion channels (see below), the question arises, whether metabotropic and ionotropic purinergic receptors may colocalize in higher order complexes, thereby further complicating the purinergic (patho)physiology and pharmacology.
Signalling via P2X receptors
Signalling via P2X receptor-channels appears to be relatively simple. These ion channels, in response to agonist challenge, allow rapid, non-selective passage of cations across the cell membrane. All P2X receptors have almost equal permeability to Na + and K + and relatively high permeability to Ca 2+ . P2X 5 receptors allow Cl − to pass as well. The time course of the effect of ATP at P2X receptors is strongly influenced by receptor desensitisation, a feature common to most ligand-gated ion channels. Recombinant P2X receptors display varying degrees of desensitisation: currents through P2X 1 and P2X 3 decline very quickly (fast desensitization-tens of milliseconds), P2X 4 exhibits moderate desensitisation (several seconds), and P2X 2 , P2X 5 and P2X 7 show less desensitisation (North 2002) . Current responses to receptor activation do not depend on the production and diffusion of second messengers within the cytosol or the membrane, and therefore, the cellular reaction time is generally very rapid (Ralevic and Burnstock 1998; Burnstock 2007) . However, additional factors may contribute to complexity. If the Ca 2+ permeability of the receptor is high, it may lead to an increase in intracellular Ca 2+ concentration and depolarization of the cell membrane, subsequently activating voltage-gated calcium channels (Erb et al. 2006 ). Thus Ca 2+ may accumulate in the cytoplasm resulting in activation of several intracellular kinases, e.g. PKC, mitogen-activated protein kinases (MAPKs) and calmodulin-calmodulin-dependent protein kinase II (CaMKII). Therefore, the overall consequence of P2X activation may be much more complex than a simple transient current flow through the membrane.
Furthermore, some P2X receptors (especially P2X 7 but, under certain conditions also recombinant P2X 2 , P2X 2/3 and P2X 4 , receptors as well as some native neuronal P2X receptors) seem to be unique in their ability to produce a large conductance pathway (pore dilation), i.e. they may become permeable to organic cations (e.g. N-methyl-D-glucamine) and fluorescent dyes following long-lasting exposure to agonists (Khakh et al. 1999; Surprenant et al. 1996; Virginio et al. 1999) . However, the incidence of pore formation and change of permeability may vary between different cell types, and differences seem to exist between various receptors (Robertson et al. 2001) . Recently, the assumption that P2X 7 receptor-channels dilate into a large membrane pore has been challenged by data supporting the involvement of hemichannels such as gap-junction proteins in the pore formation (Jiang et al. 2005b; Pelegrin and Surprenant 2006; see 5.4) .
Interaction of P2X receptors with macromolecules
Interaction of P2X receptors with macromolecules influencing receptor localization, surface expression and trafficking Clathrin-mediated endocytosis promotes internalisation of receptors, channels or other membrane proteins, thereby regulating the cell-surface expression of these proteins. Binding of clathrin to the membrane is mediated by adaptor proteins (APs), such as AP-2, the major clathrin adaptor protein at the cell membrane. Investigation of the targeting and trafficking of P2X 4 and P2X 2 receptors heterologously expressed in cultured olfactory bulb neurons showed that P2X 4 receptors undergo rapid constitutive internalisation and subsequent reinsertion into the plasma membrane, whereas P2X 2 receptors are more stable on the cell surface . Trafficking of P2X 4 receptors was dependent on dynamin, a GTPase playing a key role in the completion of clathrin-mediated endocytosis. Further experiments revealed that P2X 4 receptors are co-localized with AP-2 in clathrin-coated vesicles. It has been shown that three amino acids in the C terminus of P2X 4 (Tyr 378 , Gly 381 , Leu 382 ) compose a non-canonical tyrosine-based sorting signal of the form YXXGΦ, and this motif interacts with the µ2 (also called AP-50) subunit of AP-2. Notably, this motif is absent from other P2X subtypes, showing more stable surface localization Royle et al. 2005) . Interestingly, ivermectin, a positive allosteric modulator of P2X 4 receptors, has been suggested to interfere with clathrin/AP-2-dependent endocytosis, thereby increasing the number of cell-surface receptors (Toulme et al. 2006) . However, recent studies indicated another mechanism of action for ivermectin to potentiate the permeability of P2X 4 receptors (Jelinkova et al. 2006; Silberberg et al. 2007) . Chimeric constructions as well as scanning mutagenesis suggested that ivermectin interacts most favorably with the open conformation of the two TM helices at the protein-lipid interface (Silberberg et al. 2007 ). The involvement of residues in the TM domains and the nearby ectodomain region were also suggested to be of importance for the effect of ivermectin (Jelinkova et al. 2006) .
Meanwhile, it was demonstrated that additional trafficking signals are present in P2X subunits: a conserved YXXXK motif in P2X receptors was necessary for the stabilization of these receptors at the cell surface, possibly through direct interactions with intracellular proteins (Chaumont et al. 2004 ). The polarized expression of P2X 2 in neurons is also related to the presence of this trafficking motif, which is located in the C termini, eight residues downstream of the end of the second TM domain, in all except the P2X 7 subunit, where an extra 18-amino acid cysteine-rich domain is intercalated.
βIII tubulin, a nervous-system-specific isoform of tubulin, has been reported to interact with the P2X 2 receptor (Gendreau et al. 2003) . The tubulin-binding domain could be confined to a proline-rich segment (amino acids 371-412) of the C-terminal tail. The authors raised the possibility that this interaction might play a role in the regulation of receptor density by endo-and exocytosis as well as in anchoring P2X 2 receptors at specific sites of the plasma membrane. Furthermore, tubulin by itself could act as a cross-linking bridge bringing together receptors and modifying enzymes to participate in complex regulatory interactions. More recently, it was demonstrated, that the P2X 2 C termini interact with βI tubulin as well. However, only the long isoform of P2X 2 (P2X 2a ) and not the naturally occurring splice variant P2X 2b was able to bind βI tubulin (Guimaraes 2007) .
A P2X 1 -GFP chimaera has been used to study the time course of P2X 1 receptor clustering in plasma membranes and the internalization of the receptor following prolonged exposure to its agonists (Dutton et al. 2000) . P2X 1 receptors clustered in the plasma membranes of both Xenopus oocytes and HEK293 cells. Exposure to α,β-meATP in the presence of monensin which blocks the pH differential in endosomes led to the disappearance of the P2X 1 -GFP fluorescence from the suface of the cells apparently via endocytosis into acidic endosomes.
Interaction of P2X receptors with macromolecules regulating channel activation, desensitisation and ion selectivity Heterologously expressed channels often differ in kinetics from their native counterparts or vary between expression systems. Interaction with the actin cytoskeleton was suggested to influence the rate of desensitisation of P2X 1 (Parker 1998) . P2X 2 receptor desensitisation was also modulated by the intracellular environment . Val 370 in the C termini of P2X 2 receptors has been reported to interact with another hydrophobic region either on the receptor itself or on a different protein that is associated with the receptor (Smith et al. 1999) . Phosphatidylinositol biphosphate (PIP 2 ) positively modulates several ion channels including most P2X subtypes. In case of P2X 7 receptors, three positively charged residues located in the C termini have been found to be important for the PIP 2 -P2X 7 channel interaction (Zhao et al. 2007) . It was also reported that phosphoinositides tightly bind to the positively charged proximal region of the C termini of P2X 2 receptors, and this binding prevents channel desensitisation and alters pore dilation (Fujiwara and Kubo 2006) . It has been suggested that interaction of the P2X 2 C termini with the cytoskeleton mentioned above may also have functional consequences (Gendreau et al. 2003; Guimaraes 2007) . Furthermore, the P2X 2 C-terminal domain has been reported to co-localize and tightly interact with Fe65 and Fe65-like 1 proteins (Masin et al. 2006) . The assembly with these β-amyloid precursor-protein binding proteins regulates the functional properties of P2X 2 receptors such as pore permeability and ionic selectivity. Fe65 might also link the P2X 2 subunit to additional cytosolic proteins and the cytoskeleton.
Interaction of P2X 7 receptor with macromolecules influencing signalling and trafficking-the P2X 7 signalling complex Of the extracellular ATP-gated ion channels, especially the P2X 7 receptor-mediated effects seem to be very divergent. Activation of the P2X 7 receptor not only opens a cationpermeable ion channel (which can be dilated with time), but also results in the activation of several fundamentally different downstream-signalling pathways such as the secretion of interleukin-1β or other cytokines, the activation of phosholipase D and nuclear factor κ B (NFκB), the stimulation of MAPKs, the generation of reactive oxygen species and eventually apoptosis, shedding of membrane proteins and re-arrangement of the cytoskeleton leading to membrane blebbing may also occur (Duan and Neary 2006; Ferrari et al. 2006; Kim et al. 2001; Sperlagh et al. 2006) . Illustrating the complexity of the situation, an intricate interaction has been suggested between MAPK and NFκB pathways in modulating the responsiveness of macrophages and monocytes upon concurrent exposure to bacterial lipopolysaccharide (LPS) and P2X 7 agonists (Aga et al. 2004) .
Approximately 11 proteins have been identified that interact with rat P2X 7 receptors expressed in HEK293 cells ). This signalling complex comprises structural proteins such as the extracellular matrix protein laminin α3, the transmembrane integrin β2 and the cytoskeletal β-actin, α-actinin 4, supervillin, three heat shock proteins (HSP90, HSP70 and HSC71) and membrane-associated guanylate kinase P55. They probably play a substantial role in the anchoring of the receptor to the cytoskeleton and the cell membrane. Some of these proteins may initiate cytoskeletal rearrangements following receptor activation. Furthermore, two signalling proteins, phosphatidylinositol 4-kinase 230 and receptor protein tyrosine phosphatase β, are involved in the complex. The phosphatidylinositol 4-kinase can contribute to PIP 2 formation; therefore, it can be one of the factors enabling the P2X 7 receptor to signal via inositol triphosphate (IP 3 )-diacylglycerol (DAG) or -phospholipase D. The activity of phosphatase is increased upon receptor activation, and it might exert a feedback control on the channel itself through its dephosphorylation (Tyr 343 in the putative second TM domain) and a reduction of the receptor activity (run-down of the current). It was later demonstrated that selective tyrosine phosphorylation of the P2X 7 receptor-associated HSP90 represses the P2X 7 receptor, arguing for a regulatory, nonchaperone role of this heat-shock protein in the complex (Adinolfi et al. 2003) .
Especially the long intracellular C-terminal domain seems to be involved in the unique properties of the P2X 7 receptor (Duan and Neary 2006; Erb et al. 2006; Surprenant et al. 1996) . It associates with various epithelial membrane proteins (EMPs). The constitutive overexpression of any of the EMPs in HEK293 cells expressing P2X 7 receptors led to membrane blebbing, annexin V-binding and cell death by a caspase-dependent pathway (Wilson et al. 2002) . P2X 7 receptors have been shown to modulate LPSinduced macrophage production of numerous inflammatory mediators. The C-terminal domain of the P2X 7 receptors contains several apparent protein-protein and protein-lipid interaction motifs with potential importance to macrophage signalling and LPS action, including a Src homology 3 (SH3) binding domain, a so-called death domain implicated in caspase activity and apoptosis, as well as a conserved LPS-binding domain (Denlinger et al. 2001) . SH3 is present in a large number of eukaryotic proteins, which are involved in signal transduction (e.g. in activation of small GTPases), cell polarization and membrane-cytoskeleton interactions. Two basic residues (Arg 578 , Lys 579 ) within the latter domain are essential for LPS binding to P2X 7 in vitro. Point mutations of these two amino acids resulted in a temperature-sensitive defect in surface localization (trafficking), attenuation of channel activities and inability of pore formation (Denlinger et al. 2003) .
Caveolin-1 is a characteristic protein marker of cell-surface invaginations formed by subsets of lipid rafts implicated in signal transduction. Co-localization between P2X 7 receptors and caveolin-1 has been reported in lipid rafts in mouse lung alveolar epithelial cells (Barth et al. 2007 ). Furthermore, caveolin-1 increased the expression level of P2X 7 receptors. Notably, a recent paper suggested that caveolin-1 regulates cell polarization and directional migration in mice fibroblasts through coordination of the signaling of Src kinase and Rho GTPases (Grande- Garcia et al. 2007 ). Remarkably, caveolin-1 has been reported to associate and modulate G q -coupled P2Y purinergic receptors in glioma cells as well (Bhatnagar et al. 2004 ).
Interaction of P2X channels with gap-junction proteins-role in pore formation of P2X 7 receptors
The mechanism of pore dilation is a matter of dispute. The direct dilation hypothesis argues for the dilation of the internal pore of the P2X 7 receptor, while the separate-pore hypothesis suggests the opening of a pore associated with the receptor complex, but different from the internal pore of the receptor (Duan and Neary 2006 ). An attractive idea is that special hemichannels such as gap-junction proteins might be involved in the large pore formation, if the second hypothesis holds true. The vertebrate gap-junction formation is thought to involve the assembly of members of a family of transmembrane protein hemichannels referred to as connexins. In invertebrates, innexins seem to be involved in similar functions, but innexin-related proteins, the pannexins, have been found in vertebrates too, also involved in building of gap junctions. Indeed, the connexin Cx43 and the P2X 7 receptor have been reported to colocalize in the membrane of macrophages modulating intracellular communication (Fortes et al. 2004 ). However, the involvement of Cx43 hemichannels in ATP-induced permeabilization of macrophages seems unlikely (Alves et al. 1996) . Notably, close association of Cx43 and P2X 1 receptors was also observed in human ventricular myocardium but only in some regions of some gap junctions (Jiang et al. 2005a) . It has been suggested that gap-junctional conductance is regulated through an interaction between ATP and connexins.
Recently, large ions such as N-methyl-D-glucamine and propidium dyes were suggested to utilize different permeation pathways through rat P2X 7 receptors (Jiang et al. 2005b ). Pannexin-1, which co-immunoprecipitates with the P2X 7 protein in macrophages, is up-regulated by LPS stimulation. This pannexin is essential for caspase-1/ interleukin-1β inflammosome activation and has been implicated in the pore-forming capability of P2X 7 receptors (Pelegrin and Surprenant 2006) . Furthermore, co-expression of P2X 7 receptors and pannexin-1 in Xenopus oocytes also argued for the critical role of pannexin-1 in the formation of a permeabilization pore (or death channel) recruited into the P2X 7 receptor signalling complex (Locovei et al. 2007) . It was also elucidated that pannexin-dependent pore formation and interleukin-1β processing/release are not coupled to each other. Furthermore, pannexin-1 is involved only in the initial phase of P2X 7 receptor-mediated dye uptake (Pelegrin and Surprenant 2007) . Notably, pannexin-1 channels have been shown to be activated by metabotropic P2Y 1 and P2Y 2 purinergic receptors after heterologous expression in Xenopus oocytes and involved in ATP release, indicating its complex role in purinergic signalling (Locovei et al. 2006 ).
Interaction of P2X receptors with cell-adhesion molecules P2X 4 and P2X 6 receptors co-immunoprecipitate with Ecadherin, an endothelial cell-adhesion molecule which is located at intercellular junctions. Thereby, these purinergic receptors may play an important modulatory role in cellcell junctions in human endothelial cells (Glass et al. 2002) . Other studies demonstrated that the calcium-activated celladhesion proteins tenascin, E-cadherin and the P2X receptors are expressed in an identical spatial and temporal pattern in uterine epithelium in the rat during implantation (Slater et al. 2002) .
Selectins are another family of cell adhesion molecules; the three family members are E (endothelial)-selectin, L (leukocyte)-selectin and P (platelet)-selectin. They have an important role in inflammatory reactions, e.g. E-selectin is involved in recruiting leukocytes to the site of injury. P2X 7 receptor activation has been reported to induce E-selectin on the cell membrane of endothelial cells (von Albertini et al. 1998) . Numerous studies also demonstrated that P2X 7 receptor activation caused loss of L-selectin from the surfaces of human lymphocytes (Wiley et al. 1996) .
Physical cross-talk between P2X and Cys-loop receptors-current occlusion
The current occlusion between P2X receptors and other channels was first reported in the early 1990s, i.e. ATP-and nicotine-activated currents were not additive in PC12 cells and rat sympathetic neurons (Nakazawa et al. 1991; Nakazawa 1994) . The idea that P2X and nicotinic channels may physically interact with each other is somewhat surprising. In fact, the ATP-gated P2X receptors have little sequence, topological or structural similarity to the members of the two other large transmitter-gated channel families: the glutamate-gated (AMPA, kainate and NMDA) and the Cys-loop (nicotinic acetylcholine, ionotropic GABA A , 5-HT 3 and glycine) channels (North 1996) .
The first discernible hypothesis for the current occlusion was that ATP and nicotine, although acting on distinct binding sites, opens a common pore (channel overlap) leading to nonadditive action of the two agonists (Nakazawa et al. 1991; Nakazawa 1994 ). However, subsequent experiments revealed, that-although the P2X and nicotinic channels are, in fact, located in close proximity-they still operate via separate pores. According to this widely accepted model, a conformational change-associated gating of one receptor would hinder the function of its counterpart located in close proximity (conformational spread, Khakh et al. 2000) . Subsequently, it was elaborated that P2X receptors may interact not only with the nicotinic ACh channels but also with other members of the Cys-loop family, i.e. with the GABA A and 5-HT 3 channels. Furthermore, most experiments devoted to this issue indicated that the physical interaction occurs at the intracellular domains, i.e. the large cytoplasmic loop of the Cys-loop channels and the C terminus of the P2X receptors. Nevertheless, in addition to the physical association of the receptors, activity-dependent changes might also play an important role in the current occlusion (Sokolova et al. 2001; Boue-Grabot et al. 2003; Boue-Grabot et al. 2004a, b; Khakh et al. 2005; Toulme et al. 2007) .
Physical cross-talk between P2X receptors and nicotinic channels After the pioneering works of Nakazawa et al. (1991 Nakazawa et al. ( , 1994 demonstrating the reciprocal inhibition between ATP and nicotine, three different groups published their new data concerning this issue in 1998. Nicotinic agonists and P2X agonists have been reported to exert mutually occlusive effects on acutely dissociated guinea-pig sympathetic neurons (Searl et al. 1998 ). This interaction occurred even with concentrations of agonists that by themselves generated little or even no inward current. The effect was also observed in single-channel recording in outside-out patches. Either a heteromeric non-selective cation channel formed by subunits from P2X receptors and nicotinic receptors or co-expression of nicotinic receptors and P2X receptors were suggested as underlying mechanisms. A similar current occlusion has been reported for guinea-pig enteric neurons (Zhou and Galligan 1998) . This latter one did not involve the binding of ATP at nicotinic receptors or the binding of ACh at P2X receptors, Ca 2+ -dependent mechanisms, or a change in the driving force for Na + or cytoplasmic signalling mechanisms. Therefore, the authors concluded that other mechanisms than activation of a common set of ion channels was responsible for the observed effect. Another study also indicated that activation of nicotinic and P2X receptors opened two different channel populations, and these two sets of channels negatively modulated each other when they were simultaneously activated in guinea-pig submucosal neurons (Barajas- Lopez et al. 1998 ). This interaction occurred as soon as whole-cell currents were detected (within a few milliseconds), and were triggered by ion influx through the channels. It did not require Ca 2+ , Mg 2+ , Na + , G proteins or protein phosphorylation, suggesting that it might be the result of a direct physical association between the receptor channels. It was proposed that ion flux through one channel induced allosteric changes in the neighbouring counterpart, leading to its blockade, so that two channels of a particular functional unit were never open at the same time.
Further studies provided a molecular basis and a synaptic context for cross-inhibition between nicotinic and P2X receptors in the nervous system. P2X 2 and α 3 β 4 nicotinic channels were expressed in Xenopus oocytes (Khakh et al. 2000) . During their co-activation, substantial proportions of the nicotinic channels failed to open or opened less frequently, and the authors provided direct evidence that nicotinic channels close when P2X 2 channels open (state-dependent inhibition). The cross-inhibition was decreased at lower densities of channel expression. The current occlusion was observed in cells co-expressing P2X 4 and α 3 β 4 nicotinic channels as well. It was suggested that a non-competitive mechanism: conformational spread (conformational change-associated gating of one receptor hinders the function of its counterpart located in close proximity) accounted for the current occlusion.
Subsequent studies provided direct evidence for the close spatial apposition of P2X 2 and α 4 β 2 nicotinic channels in the plasma membrane of HEK293 cells and of hippocampal (but not of midbrain) neurons (Khakh et al. 2005) . FRET analysis revealed that the P2X 2 subunit interact specifically with the β 2 subunit of the nicotinic channels. The channels form a molecular-scale partnership within 100 nm of the plasma membrane of living cells. Hence, it was unequivocally elucidated that close proximity of the separated channels and a direct physical interaction between them is the most plausible reason for the current occlusion between nicotinic and purinergic channels.
Functional P2X-like receptors responding to diadenosine pentaphospate and nicotinic receptors co-expressed in rat midbrain cholinergic terminals have been reported to exhibit an inhibitory interaction detected by calcium microfluorimetric studies (Diaz-Hernendez et al. 2004 ). However, the inhibitory cross-talk involved the Ca 2+ /CaMKII pathway, therefore in this case, other mechanisms than a simple statedependent conformational spread could account for the observed effect. Whole-cell patch-clamp recordings and fura-2 microfluorometry revealed a negative interaction between P2X receptors and nicotinic ACh channels in neurons acutely dissociated from rat area postrema as well (Sorimachia et al. 2006 ). The inhibitory interaction required both the simultaneous activation of the involved receptor channels and a substantial inward current flow of cations through the activated P2X receptors and nicotinic channels. Recently, a tight, cross-antagonistic interaction between nicotinic ACh receptors and P2X channels has been demonstrated in the control of glutamate release from hippocampal nerve terminals (Rodrigues et al. 2006) . The authors hypothesized that the P2X receptor/nicotinic channel device would be well suited to allow nicotinic ACh receptors to function at moderate firing frequencies (where ATP release is low) and to blunt nicotinic responses at higher frequencies where ATP release is disproportionately higher.
Physical cross-talk between P2X receptors and GABA channels Patch-clamp recordings and intracellular Ca 2+ imaging of rat cultured DRG neurons revealed that ATP gated channels negatively interact with another member of the Cys-loop channel family: the ionotropic GABA A receptor (Sokolova et al. 2001) . Since all types (fast, slow and mixed) of responses to ATP could undergo occlusion with GABA currents, it appeared to be a general phenomenon, not linked to any particular ATP receptor type in DRGs. Further analysis of the effect revealed that preapplied GABA more strongly depressed ATP currents than pre-applied ATP the GABA currents, i.e. the current occlusion was not completely reciprocal. The inhibition of ATP currents was dependent on chloride efflux via GABA A receptors and local changes in the extracellular chloride concentration. Intracellular Ca 2+ has been reported to play a significant cross-talk-facilitating role.
Another kind of P2X-GABA A inhibitory cross-talk was reported in a heterologous expression system. Current occlusion between inhibitory GABA C ρ1 and excitatory P2X 2 receptor channels co-expressed in Xenopus oocytes was reciprocal, receptor mediated, independent of agonist cross-modulation, membrane potential, direction of ion flux, or channel densities (Boue-Grabot et al. 2004a ). Furthermore, results of mutagenesis and competition experiments underlined the importance of intracellular domains (C-terminal domain of the P2X 2 and the main intracellular loop of the ρ1 subunit). Co-expression in hippocampal neurons transfected with the ρ1 subunit and with P2X 2 receptors resulted in a dramatic change in the distribution of GABA C receptors that were translocated from the cytoplasm to the cell surface and co-localized with P2X 2 clusters. It was suggested that molecular and functional cross-talk of the two receptor types may regulate synaptic strength by activity-dependent current occlusion and co-trafficking of synaptic receptors.
Subsequently, the same laboratory reported that coactivation of P2X 2 receptors and various GABA A receptors both in Xenopus oocytes and transfected hippocampal neurons leads to a functional cross-inhibition (Boue-Grabot et al. 2004b ). The current occlusion was independent of membrane potential, changes in current direction, and calcium and chloride concentrations. Mutagenesis studies and competition experiments argued again for the involvement of intracellular domains (C-terminal of the P2X 2 receptor and the large intracellular loop of the GABA A β3 subunit) in the functional cross-talk. Sequential application of GABA and ATP revealed that, while all GABA A receptors containing various subunits inhibited P2X 2 channels, P2X 2 channel activation failed to inhibit GABA A receptors containing γ2 or γ3 subunits. Therefore, it was suggested that in the mixed ATP/GABA A synapses, where GABA A receptors contain γ subunits (e.g. dorsal horn of the spinal cord or the lateral hypothalamus), the cross-talk may have stronger effects on the ATP component. In other cases, the current occlusion may be completely reciprocal.
A recent electrophysiological study combined with molecular biology, receptor mutagenesis and immunohistochemistry in DRG neurons clarified the molecular basis of the P2X 3 -GABA A current occlusion (Toulme et al. 2007) . A specific intracellular QST 386-388 motif was identified within the P2X 3 C-terminal domain, which is required for the functional coupling with GABA A receptors (most likely interacting with its intracellular loop on the β subunit). Conflicting with the results of Sokolova et al. (2001) , the authors reported that the cross-inhibition did not depend on Cl − and Ca 2+ ions and suggested the conformational spread model to explain the observed cross-inhibition.
Although Zhou and Galligan (1998) reported that in guinea-pig myenteric neurons P2X channels interact specifically with nicotinic channels (see above) but not with other members of the Cys-loop superfamily, a recent study demonstrated current occlusion between GABA A and P2X channels in myenteric neurons from the guinea-pig small intestine (Karanjia et al. 2006) . This interaction was concentration-dependent (required total saturation of at least one of these receptors), but independent from Ca 2+ , G proteins or protein phosphorylation. The authors suggested that the interfering receptors are located very close to each other, perhaps forming functional units consisting of at least one channel of each type, thereby influencing each other-consistent with the model of conformational spread.
Physical cross-talk between P2X receptors and 5-HT 3 channels In contrast to the report of Zhou and Galligan (1998; see above) , a direct inhibitory interaction between P2X and 5-HT 3 channels was also observed in guinea-pig submucosal neurons (Barajas-Lopez et al. 2002) . The current occlusion was observed as soon as the currents were activated; it was voltage-dependent (present at negative holding potentials for inward currents but not present at +40 mV for outward currents) and did not require Ca 2+ , Mg 2+ and G protein activation or protein phosphorylation. In agreement with the general model for the P2X-Cys-loop channel interactions, it was hypothesized that the involved channels are located very close to each other, perhaps forming functional units (clusters), thereby enabling the direct physical inhibitory interaction. Subsequently, the physical association (co-immunoprecipitation and co-clustering) of P2X 2 and 5-HT 3 receptors has been proven in guinea-pig myenteric neurons as well as in heterologous systems (expression in Xenopus oocytes or HEK293 cells; Boue-Grabot et al. 2003) . Furthermore, combined mutagenesis and electrophysiological studies demonstrated that specific intracellular domains, namely the intracellular loop of the 5-HT 3A subunit and the Cterminal domain of the P2X 2 receptor, are necessary for the development of the cross-inhibition.
A recent report provided a hint that P2X and 5-HT 3 receptors may be functionally associated and negatively interact in pelvic afferents and DRG neurons (Ma et al. 2006 ). Whole-cell patch-clamp experiments showed that the amplitude of 5-HT-induced currents was significantly higher in DRG cells obtained from mice deficient in P2X 2 and/or P2X 3 receptors compared with preparations obtained from wild-type mice. It was suggested that the removal of P2X receptors resulted in adaptive increase in 5-HT 3 -mediated signalling in the pelvic afferent neurons.
Data regarding glycine channels Hence, accumulated data support the idea that rapid physical inhibitory interactions between P2X receptors and members of the Cys-loop channel family might be a widely used mechanism to limit the ionic currents through the cellular membrane. However, one member of the Cys-loop family is missing from the list of interacting partners of purinergic receptors: the strychninesensitive glycine receptor.
Interestingly, double-immunostaining experiments revealed that all cells of spinal cord neurons exhibiting glycine receptor immunoreactivity also showed P2X 2 (and P2X 4 ) immunoreactivity (Laube 2002) . Furthermore, a partial co-localization of the P2X 2 receptor with the inhibitory glycine receptor was observed, i.e. P2X 2 immunoreactive patches were found in close proximity to and sometimes partially overlapping with patches of glycine receptor immunoreactivity. It is noteworthy, that Zn 2+ -potentiated glycinergic inhibitory postsynaptic potentials (IPSCs) and P2X receptor antagonists could block this effect. However, this P2X-glycine interaction involved presynaptic mechanisms.
Potentiation of Cys-loop channels by P2X receptors
In contrast to the above-mentioned studies, a recent paper reported that co-localized P2X and nicotinic channels might be able to interact positively with each other (Patti et al. 2006) . P2X 7 receptors and α7 nicotinic ACh receptors coexisting on glutamatergic nerve terminals were suggested to cooperatively interact to increase excitatory amino acid release. Although the authors did not provide unequivocal evidence that the two channels are co-localized on the same terminal, their results with superfused purified rat neocortical synaptosomes suggested that the receptor channels coexist on the same axon terminal and cross-talk with each other. Peculiar characteristics of the α7 nicotinic ACh receptors are that they cannot mediate glutamate release under membrane-resting condition but require depolarisation. From this point of view, the explanation for this interaction may be that the activation of P2X 7 receptors by depolarising the membrane would permit activation of the nicotinic channels to mediate glutamate release.
Interaction of P2X receptors with GPCRS
Both the N and C termini of P2X receptors may contain consensus phosphorylation sites for protein kinases [PKC, protein kinase A (PKA), casein kinase, CaMKII] (Mager et al. 2004 ). The stimulation of G protein-coupled receptors may activate, e.g. PKC, which, by phosphorylating P2X receptor-channels themselves or an associated regulatory protein, could increase the conductance of these channels or their desensitization kinetics.
The neuropeptides bradykinin and substance P, known to modulate pain perception, potentiated currents through recombinant homomeric P2X 3 and heteromeric P2X 2/3 receptors (Paukert et al. 2001 ). This effect was abolished by PKC inhibitors and was mimicked by phorbol esters with PKC activator properties. Later, the potentiation of cationic currents was also confirmed in rat DRG neurons through native P2X 3 and P2X 2/3 receptors by using neurokinin B as an NK3 receptor agonist (Wang et al. 2001) . It should be noted, however, that Brown and Yule (2007) failed to supply evidence for a direct phosphorylation of the P2X 3 receptors and favored an effect via the phosphorylation of an associated protein.
More recently, an interaction between P2X 3 and other pain-relevant GPCRs has been demonstrated. Agonists at both opioid μ (Chizhmakov et al. 2005 ) and cannabinoid CB 1 receptors (Krishtal et al. 2006 ) inhibited P2X 2/3 receptor-mediated currents in rat DRG and nodose ganglion neurons. These effects appeared to depend on coupling to a pertussis toxin (PTX)-sensitive G protein (most probably G i/o ) and, at least in the case of the opioids, on the subsequent activation of PKA. In contrast, a G q proteindependent inhibitory interaction between P2Y 1 and P2X 3 receptors in dorsal-root ganglia has been observed in our laboratory . This effect was confirmed in a later study on HEK293 cells transfected with recombinant P2X 3 receptors, and it has been revealed that the underlying mechanism of this interaction is a G proteindependent facilitation of the P2X 3 receptor desensitisation and a suppression of the recovery from the desensitised state (Gerevich et al. 2007) .
Several GPCRs such as metabotropic glutamate receptor 1α, P2Y 1 and P2Y 2 have been reported to potentiate currents through P2X 1 receptors following co-expression in Xenopus oocytes. The potentiation did not result from increased trafficking of P2X 1 receptors to the cell surface or phosphorylation of the conserved PKC site on the P2X 1 receptor, but most probably via protein kinase-induced phosphorylation of an associated regulatory protein (Vial et al. 2004) . Notably, a previous study showed that P2X 1 receptor activation potentiated subsequent P2Y 1 receptormediated calcium rises; thereby, P2X 1 receptors have been suggested to play a priming role in the subsequent activation of metabotropic P2Y receptors during platelet stimulation (Vial et al. 2002) .
Signalling via P2Y receptors
Interaction with heterotrimeric G proteins
The heterotrimeric G proteins are composed of α and the tightly associated βγ subunits. P2Y receptor agonists conforming with other GPCR-ligands cause the dissociation of the α subunit from the βγ dimer after binding to their receptors. Then, the Gα or, in some cases, the βγ subunit initiates the further downstream events.
Based on the identity of the α subunit in the trimeric complex, four main heterotrimeric G protein subfamilies have been characterized (G s , G i/o , G q/11 and G 12/13 ), and individual P2Y receptor subtypes may be linked to one or more of these proteins Erb et al. 2006) . Gα s subunit-activation stimulates adenylate cyclase yielding cAMP and activation of PKA, which in turn can phosphorylate various intracellular targets. Nevertheless, G s proteins do not seem to play an important role in P2Y signalling, although P2Y 11 receptors have been reported to couple to this G protein (Communi et al. 1997) .
The G i/o subfamily is more important for P2Y receptor functions, since the P2Y 12 , P2Y 13 and P2Y 14 subtypes bind preferentially G proteins containing the Gα i/o subunit. Furthermore, coupling of P2Y 2 , P2Y 4 and P2Y 11 to G o was also reported. G i activation is classically associated with inhibition of adenylate cyclase and decreased cAMP production, but the activation of the G i/o subunit may have also other consequences (Bagchi et al. 2005; Chambers et al. 2000; Communi et al. 1996 Communi et al. , 2001 Erb et al. 2001 Erb et al. , 2006 Filippov et al. 2003; Hollopeter et al. 2001 ). For instance, P2Y 2 , P2Y 4 , P2Y 13 and P2Y 14 via G i/o stimulates membrane-bound phospholipase C (PLC), which then cleaves PIP 2 in the membrane into two second messengers, IP 3 and DAG. Membrane-bound PIP 2 itself might fulfil important biological functions, such as regulation of ion channel activity; its depletion may have therefore the appropriate consequences. IP 3 mobilizes intracellular calcium, while DAG-in the presence of calcium-activates PKC, leading to phosphorylation of intracellular macromolecules. Ca 2+ can form a complex with the Ca 2+ -binding protein calmodulin, thereby activating the CaMKs. Furthermore, G o coupling of P2Y 11 receptors in response to UTP activation may result in PLC-independent Ca 2+ -release, while ATP has been reported to activate the classical (probably G q -mediated) PLC-dependent Ca 2+ mobilization mechanisms of the P2Y 11 receptor (White et al. 2003) .
Another important downstream signalling pathway of P2Y receptors is coupling to G q/11 proteins and activation of the previously described PLC-IP 3 -DAG-Ca 2+ -release as well as PKC and/or CaMK mechanisms Communi et al. 1996; Erb et al. 2006; Simon et al. 1995; Volonte et al. 2006; White et al. 2003) . This was observed in case of the P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 and P2Y 11 receptors. Gα 12/13 subunits are involved in the activation of small homomeric GTPases, as in case of P2Y 2 or P2Y 12 receptors. Nevertheless, other Gα (or βγ) subunits may also be involved in this type of effect (see below).
Interaction of P2Y receptors with small homomeric G proteins
The small GTPases do not interact directly with GPCRs. However, it was observed that activation of the Gα 12/13 subunit of heteromeric G proteins typically resulted in activation of Rho guanine nucleotide exchange factors (GEFs), which in turn activate Rho, a small homomeric G protein. This mechanism is involved in the control of cellcytoskeleton remodelling and thereby in cell migration. This kind of signalling was observed for P2Y 2 and P2Y 12 receptors (Liao et al. 2007; Soulet et al. 2004 ). P2Y 12 receptor activation has also been reported to increase cell proliferation in C6 glioma cells via G i and the RhoAdependent MAPK pathway (van Kolen and Slegers 2006). Furthermore, in rat vascular myocytes, P2Y 1 , P2Y 2 , P2Y 4 and P2Y 6 receptors have been reported to couple to Rho GTPase (Sauzeau et al. 2000) . P2Y-dependent Rho GTPase activation was demonstrated in endothelial cells as well Tanaka et al. 2005) .
Similarly, G i/o -proteins, probably via their βγ subunits, can activate RacGEFs, and consequently another homomeric GTPase, Rac. This mechanism is also implicated in the P2Y-receptor signalling, especially with P2Y 2 receptors. It was reported to contribute to cell migration (Honda et al. 2001; Bagchi et al. 2005) . P2Y 1 receptors may also activate Rac GTPase, regulating dynamics of the actin cytoskeleton via a G q -dependent mechanism in platelets (the role of GEFs was not proved in this case). In platelets, when the IgG receptor FcγRIIA activated Rac GTPase, P2Y 12 receptors functioned as coactivators via a G i protein (Soulet et al. 2005) . Similarly, P2Y 1 was required for activation of Rho-mediated signalling in platelets, and P2Y 12 was able to potentiate this effect (Hardy et al. 2005) . Both Rho and Rac downstream effectors were involved in UTP-promoted migration of hematopoietic stem cells, and converging signaling path-ways have been demonstrated between CXCR4 (a receptor for an α-chemokine) and P2Y receptors, involving Gα i proteins and Rho GTPases (Rossi et al. 2007) .
These examples indicate that the P2Y receptor signalling is much diversified. A given receptor subtype may couple to various signalling mechanisms; for instance, the P2Y 11 receptor is able to couple to G q/11 , G s and G o proteins, or the P2Y 2 receptor may utilize the G q/11 , G o , G 12/13 , Rho or Rac GTPase-mediated downstream mechanisms.
Interaction of P2Y receptors with the MAPK/extracellular signal-regulated kinase pathway
In addition to the previously mentioned classical downstream effectors such as PLC-IP 3 -DAG-Ca 2+ and PKC or cAMP-PKA, we should consider another important kinase family and its role in the purinergic signalling, namely the MAPK/extracellular signal-regulated kinase (ERK) pathway. This pathway plays central roles in controlling diverse cellular functions, such as gene expression, metabolism, cell division, differentiation, and cell survival/apoptosis. It is activated by growth factors, cytokins as well as interleukins, and this activation typically involves small GTPases. However, activation of classical heteromeric G proteins can also lead to the triggering of this pathway. Several subfamilies of MAPKs have been identified in mammalian species, such as the classical MAPK/ERK, the Jun N-terminal kinases, the p38 kinases and the newly recognized ERK3/ERK4 as well as ERK5.
It is well known that besides the short-term signalling actions, extracellular ATP also exerts trophic actions, and the MAPKs play a prominent role in these effects (Neary 2000) . The activation of several P2Y receptors especially P2Y 1 and P2Y 2 is commonly associated with the stimulation of several MAPKs Erb et al. 2006 : Gao et al. 1999 .
Since the MAPK cascade is a complex signalling system, it provides the background for multiple interactions at this level (D'Ambrosi et al. 2001 ). Indeed, both ATP acting via P2Y receptors and fibroblast growth factor-2 via its own receptor induced proliferation in astrocytes by involvement of the MAPK cascade. Although the activation of the signalling pathway resulted in synergism of cell proliferation, an inhibitory link via ATP on the fibroblast growth factor-induced signalling was observed: ATP inhibited the activation of cRaf-1, which participates in MAPK signalling of the growth factor, thereby influencing the time course and the maximal intensity of cell proliferation (Lenz et al. 2001 ). The ADP-induced thromboxane generation in platelets requires signalling events from the G q -coupled P2Y 1 receptor and the G i -coupled P2Y 12 receptor . ERK2 activation occurred as a downstream event of the stimulation of both types of P2Y receptors by ADP. Inhibitors of Src family kinases or the ERK upstream kinase MEK abrogated ADP-induced ERK phosphorylation and thromboxane A2 generation. Hence, it has been shown that ERK2 was activated downstream of P2Y receptors through a complex mechanism involving Src kinases, and this played an important role in ADP-induced thromboxane generation.
Both A 2B adenosine (via G q/11 and G s ) and P2Y 2 receptors (via G q/11 ) have been reported to activate MAPK in HEK293 cells. The G s downsteam signalling had a positive modulatory link via PKA on the G q/11 -mediated MAPK activation (Gao et al. 1999 ). Co-stimulation of the G q/11 -coupled P2Y 2 receptors and the G i/o -linked M 2 muscarinic receptors caused a tenfold leftward shift in the M 2 receptor-stimulated ERK response in Chinese hamster ovary cells, indicating interplay between the signalling systems (Hornigold et al. 2003) .
Furthermore, although insulin counteracted cationic currents and intracellular Ca 2+ increase induced by ATP via a G q -coupled receptor in rat hepatoma cells, it potentiated MAPK responses to ATP; Ca 2+ played a permissive role in this synergistic interaction (Haddad et al. 2003) . In platelets, ADP alone failed to induce MAPK activation; G i -coupled P2Y 12 and G q -coupled thromboxane A 2 receptors were also required for the full effect (Roger et al. 2004 ).
Interaction of P2Y receptors with integrins
If the interaction of some (if not all) P2Y receptor types with the downstream signalling elements are so promiscuous as it was previously described, we may ask the question, how can a given receptor select in the given cell the appropriate partner? The involvement of the cell adhesion molecules, especially the integrins, might help us to answer this question. Integrins are transmembrane proteins with three domains; they bind to the extracellular matrix or other integrins via their extracellular domains as well as to the cytoskeleton via their intracellular domains.
It has repeatedly been demonstrated that platelet P2Y 12 receptors are critically involved in the activation of the integrin α IIb β IIIa , also known as glycoprotein IIbIIIa, and the subsequent binding of fibrinogen or other proteins aggregating the platelets (Hollopeter et al. 2001) . Furthermore, the efficient induction of platelet aggregation through GPCRs has been reported to be an integrated response caused by various converging G protein-mediated signalling pathways involving G q -(e.g. with P2Y 1 , or thromboxane A 2 ), G i -(P2Y 12 ) and G 12/13 -(thromboxane A 2 ) coupled receptors . For instance, the activation of thromboxane A 2 or P2Y 12 receptors alone (which, in Gα qdeficient platelets couple to G 12/13 and G i , respectively) did not induce platelet integrin activation or aggregation, but their concomitant activation resulted in irreversible integrin α IIb β 3 -mediated aggregation of Gα q -deficient platelets (Nieswandt et al. 2002) . Platelet ADP receptors P2Y 1 and P2Y 12 are also involved in platelet activation via stimulating the integrin α 2 β 1 (Jung and Moroi 2001) . In platelets, α v β 3 mediates platelet adhesion to the matrix protein osteopontin, and probably, it is the predominant integrin mediating platelet adhesion to the matrix protein vitronectin. Concurrent stimulation of the G q -coupled P2Y 1 and the G i -coupled P2Y 12 is required to activate α v β 3 (Paul et al. 2003) .
Integrins may regulate the P2Y (and other GPCR) signalling pathways by permitting efficient coupling to cell constituents involved in the signal transduction cascade. In human endothelial cells, P2Y receptors activated by both ATP and UTP were presumably linked to G q/11 -protein activated MAPKs (but not IP 3 ), and this effect was dependent on integrin-mediated anchorage (Short et al. 2000) . P2Y 2 receptors possess in their first extracellular loop an Arg-Gly-Asp (RGD) domain known to bind integrins. P2Y 2 receptors have been reported to interact with integrins in human erythroleukemia cells transfected with P2Y 2 receptors. Mutagenesis studies confirmed that the P2Y 2 receptor via its RGD domain attached selectively to α V β 3 /β 5 integrins and the integrinassociated thrombospondin receptor, CD47. CD47 binds directly to G i/o family proteins (Bagchi et al. 2005; Erb et al. 2001 ). The P2Y 2 -integrin association was necessary for P2Y 2 receptor-mediated activation of G o , but not G q , and the G o -mediated events resulted in chemotaxis of human astrocytes. P2Y 2 receptors in human monocytic cells also regulated the activation of MAPKs by inducing the clustering of α v integrins (Chorna et al. 2007 ). It was elucidated that P2Y 2 receptors interacting with α v integrin complexes activate G 12 and associated signalling pathways (Liao et al. 2007 ). This mechanism controls actin cytoskeletal rearrangements required for chemotaxis in human astrocytoma cells.
Osteopontin, an extracellular matrix protein, is a ligand of α V β 3/5 integrin receptors. UTP via P2Y receptors has been reported to induce arterial smooth-muscle-cell migration. This effect was mediated via osteopontin production and α V β 3/5 integrin, as well as the MAPK pathway activation (Chaulet et al. 2001 ). Silencing of P2Y 2 receptor expression with short interfering RNA inhibited UTPinduced astrocyte migration. UTP also increased the expression of α V β 3/5 integrins in astrocytes. Anti-α V integrin antibodies prevented UTP-stimulated astrocyte migration, which required the activation of the phosphatidylinositol-3-kinase/protein kinase B and the MAPK signalling pathways, responses that were also inhibited by anti-α V integrin antibody (Wang et al. 2005) . The ADPinduced chemotaxis of microglia was mediated by P2Y 12/13 receptors, and this effect was dependent on β 1 integrin and fibronectin (Nasu-Tada et al. 2005) .
Articular chondrocytes respond to purine and pyrimidine nucleotides by elevation of cytosolic free Ca 2+ concentration and activation of MAPKs (Kudirka et al. 2007 ). Phospholipase D and PKC were identified as key effectors linking P2Y receptors to MAPKs. Moreover, P2Y signalling to MAPKs was dependent on β 3 integrin ligation and, therefore, was influenced by the composition of the extracellular matrix.
In contrast, activation of P2Y 2 receptors via Gα q/11 inhibited keratinocyte cell spreading, caused lamellipodium withdrawal, and delayed growth-factor-induced wound healing of keratinocyte monolayers (Taboubi et al. 2007 ). P2Y 2 -receptor activation also produced a dramatic dismantling of the actin network, the loss of α 3 integrin expression at the cell periphery, and the dissolution of focal contacts, as indicated by the alteration of α v integrins and focal contact protein distribution. In addition, activation of P2Y 2 receptors prevented growth-factor-induced phosphorylation of MAPKs and other kinases.
Interaction of P2Y receptors with tyrosine kinases and with receptor tyrosine kinases
Two proline-rich SH3 binding domains have been identified in the C-terminal tail of the human P2Y 2 nucleotide receptor that were directly associated with the tyrosine kinase Src (Liu et al. 2004) . Src co-precipitated with the P2Y 2 receptor in astrocytoma cells stimulated with P2Y 2 agonists. P2Y 2 -receptor activation also caused a co-localization of P2Y 2 and the epidermal growth factor receptor (EGFR). A Src inhibitor prevented this effect. It was suggested that the agonist-induced binding of Src to the SH3-binding domain in the P2Y 2 receptor facilitated Src activation, which recruited EGFR into a protein complex with the P2Y 2 receptor and allowed Src to efficiently phosphorylate EGFR. Similarly, activation of the P2Y 2 receptor induced rapid tyrosine phosphorylation of vascular endothelial growth factor receptor (VEGFR)-2 in human coronary artery endothelial cells ). VEGFR-2 and the P2Y 2 receptor co-localized upon UTP stimulation. Investigation of the underlying mechanism revealed that activation of the P2Y 2 receptor promoted Src binding to SH3-binding motifs in the P2Y 2 receptor and facilitated the interaction and transactivation of VEGFR-2. This interaction resulted in the sequential activation of Vav2 and RhoA, finally leading to vascular cell adhesion molecule (VCAM-1) expression.
Activation of the P2Y 2 receptor by ATP-γ-S, and the tyrosine receptor kinase A (TrkA) by nerve growth factor resulted in co-localization of these receptors, indicating a physical association regulated by receptor stimulation (Arthur et al. 2005) . The convergence of the TrkA and P2Y 2 -receptor signalling resulted in increased MAPK activation by phospho (P)-TrkA, leading to increased neurite formation in both PC12 cells and DRG neurons. The authors suggested that enhancement of P-TrkA formation by P2Y 2 activation was a crucial interaction between TrkA and P2Y 2 signalling. Subsequently, Src family kinases have been identified as a key convergence point for this P2Y 2 -TrkA molecular crosstalk (Arthur et al. 2006) .
More recently, a novel type of cross-talk between P2Y 12 and insulin-like growth factor I (IGF-I) receptor tyrosine kinase has been reported that proceeds through Gβγ-, Ca 2+ -and phospholipase D (PLD)-dependent activation of the proline-rich tyrosine kinase 2/Src tyrosine kinase pathway, resulting in GTP loading of Rap1 GTPase and increased PKB phosphorylation in glioma cells ).
Interaction of P2Y receptors with PDZ proteins PDZ domains are conserved protein modules that mediate protein-protein interactions. These domains bind to the Cterminal tails of target proteins. The scaffolding protein Na + / H + exchanger regulatory factor (NHERF) contains two PDZ domains. NHERF-besides the β 2 adrenergic receptorbinds to the C-terminal tail of P2Y 1 receptors and the cystic fibrosis trasmembrane conductance regulator (CFTR; Hall et al. 1998) . A more recent study showed a specific interaction with the second PDZ domain of the scaffold NHERF-2 and P2Y 1 receptors (Fam et al. 2005) . Furthermore, P2Y 1 receptor and NHERF-2 associated in cells, allowing NHERF-2-mediated tethering of P2Y 1 receptor to key downstream effectors, such as PLCβ. Co-expression of P2Y 1 receptors with NHERF-2 in glial cells prolonged P2Y 1 receptor-mediated Ca 2+ signalling, whereas disruption of the P2Y 1 -NHERF-2 interaction by point mutations attenuated the duration of P2Y 1 -mediated Ca 2+ responses.
Interaction of P2Y receptors with other GPCRs
In HEK293 cells, pre-stimulation of P2Y nucleotide receptors, particularly P2Y 2 , facilitated Ca 2+ signalling by either recombinant G i protein-coupled chemokine CXCR2 receptors or endogenous β adrenergic receptors (Werry et al. 2002; Werry et al. 2003) . The subsequent experiments revealed that this interaction was dependent on PLC-IP 3 -Ca 2+ release. However, activation of PLC occurred through synergistic actions of Gα q and Gβγ subunits derived from G i . The authors suggested that Gα q and Gβγ subunits are derived from activated P2Y 2 and CXCR2 receptors, respectively. More recently, UTP has been reported to physiologically modulate the homing of haematopoietic stem cells to the bone marrow, in concert with the chemokine CXCL12, via the activation of converging signalling pathways between CXCR4 chemokine receptors and P2Y receptors, involving Gα i proteins and Rho GTPases (Rossi et al. 2007 ). P2Y 1 and P2Y 2 purinergic as well as β 2 adrenergic and A 2A adenosine receptor co-expression with M71 olfactory receptors selectively and markedly enhanced the plasma membrane localization of this olfactory receptor in HEK293 cells (Bush et al. 2007 ). Furthermore, the M71 olfactory receptor coupled to a G o -protein, and co-immunoprecipitated with the purinergic receptors.
The G protein coupled leukotriene CysLT 1 receptor was the target for both agonist-mediated homologous desensitisation, and P2Y receptor-mediated heterologous desensitisation in human monocyte/macrophage-like dU937 or COS-7 cells (Capra et al. 2005) . Desensitisation and trafficking of the CysLT 1 receptor was regulated differently by its cognate ligand LTD 4 or by ATP and UDP. The receptor cross-regulation was unidirectional, since activation of the CysLT1 receptor by LTD 4 had no effect on P2Y receptor responses. Although the CysLT1 receptor is promiscuously coupled to G q and G i in dU937 cells, P2Y agonist-induced heterologous desensitisation affected mostly the G i coupling. More recently, the same group of authors reported that GPR17, a G i -coupled orphan receptor at intermediate phylogenetic position between P2Y and CysLT receptors, is specifically activated by both families of endogenous ligands (Ciana et al. 2006 ). This receptor is highly expressed in the organs typically undergoing ischemic damage, that is, brain, heart and kidney. In vivo inhibition of GPR17 by either CysLT/P2Y receptor antagonists or antisense technology dramatically reduced ischemic damage in a rat focal ischemia model, suggesting GPR17 as a common molecular target mediating brain damage by nucleotides and CysLTs.
In cerebellar astrocytes, a complex cross-talk has been suggested to occur between G q -protein-coupled receptors for Ap 5 A, EGFR receptors (a receptor tyrosine kinase) and P2Y 2/4 receptors (Delicado et al. 2006 ). Activation of P2Y 1 receptors triggered the PKC-and CaMKII-dependent internalization of a metabotropic glutamate receptor (mGluR) splice variant mGluR1α in HEK293 cells (Mundell et al. 2004) . P2Y 2 receptor activation has been reported to inhibit β 2 adrenergic receptor-mediated cAMP generation in mouse pineal-gland tumor cells (Suh et al. 2001 ).
Interaction of P2Y receptors with ion channels
A typical effect of GPCRs is that they regulate activity of ion channels. The classical (G protein-dependent) downstream signalling, mostly via activation of protein kinases, can lead to indirect effects on ion channels. However, P2Y receptors can also modulate the function of ion channels in a more specific and more direct manner, i.e. through protein-protein interactions at the plasma membrane that do not necessarily involve soluble second-messenger molecules .
Interaction of P2Y receptors with sodium channels There are only few hints suggesting the possibility that P2Y receptors act at voltage-sensitive sodium channels. P2Y receptors, presumably in association with PTX-sensitive G proteins, as well as voltage-sensitive Na + channels and Ntype voltage-dependent calcium channels, have been suggested to be involved in the ATP-induced release of dopamine in the striatum (Zhang et al. 1995) . However, in the case of voltage-sensitive Na + channels, although ATP increased the respective Na + currents, purinergic receptors did not seem to be involved in the observed interaction (ElSherif et al. 2001; Joo Choi et al. 2003) . Hence, a direct action of ATP on the sodium channel may occur instead. Nevertheless, a recent study indicated that ATP, presumably via G q/11 protein-coupled P2Y receptors and the activation of PKC, up-regulated tetrodotoxin (TTX)-resistant, persistent sodium currents (Na v 1.9) in rat and mouse sensory neurons (Baker 2005) . This up-regulation can generate steady-state currents, large enough to depolarise the membrane potential, and might explain why selective activation of P2Y 2 receptors produces a prolonged period of action potential firing in cultured sensory neurones (Molliver et al. 2002) .
On the other hand, purinergic agonists attenuate amiloride-sensitive Na + transport, probably by inhibition of epithelial sodium channels (ENaC)s in native airway epithelial cells and renal collecting ducts (Cuffe et al. 2000; Devor and Pilewski 1999; Kunzelmann et al. 2002; Lehrmann et al. 2002; Mall et al. 2000; Ramminger et al. 1999) . Further analysis of the inhibitory action revealed that stimulation of P2Y 2 receptors regulates Na + absorption probably via a direct G q protein-mediated mechanism. The classical downstream signalling involves generation of DAG and IP 3 , leading to increases in intracellular Ca 2+ and activation of PKC, known to inhibit ENaC. However, P2Y 2 -dependent inhibition of ENaC was not mediated via elevation of intracellular Ca 2+ or PKC in mouse cortical collecting duct cells (Thomas et al. 2001) . PIP 2 is known to be involved in the activation of various channels (see above). P2Y 2 receptors activating PLCβ and stimulating the rapid hydrolysis of phospholipids deplete PIP 2 in the cell membrane. ENaCs seem to be directly inhibited by PIP 2 depletion (Huang et al. 2004; Kunzelmann et al. 2005; Ma et al. 2002; Ma and Eaton 2005) . Recent data suggested the involvement of the MAPK pathway in the P2Y-dependent inhibition of ENaC (Kunzelmann et al. 2006 ). Deletion of P2Y 2 receptors resulted in facilitated renal Na + and water reabsorption, confirming the importance of this receptor type in the regulation of the amiloride-sensitive Na + transport (Rieg et al. 2007) . A recent paper delineated that luminal nucleotides via a luminal P2Y 2 receptor, colocalized with the ENaC channel in surface epithelial cells, inhibit electrogenic amiloride-sensitive Na + absorption in mouse distal colon as well (Matos et al. 2007 ).
In contrast to these studies, ATP via P2Y receptor activation has been reported to increase Na + transport in middle-ear epithelium (Yen et al. 1997) . Similarly, in human mammary epithelial cells, Ca 2+ mobilization evoked by P2Y receptors stimulated Na + absorption by activating Ca 2+ -activated K + channels located in the basolateral membrane (Lee et al. 2007 ).
Interaction of P2Y receptors with voltage-activated calcium channels Voltage-activated calcium channels (VACCs) are regulated by various G protein-coupled receptors, including P2Y receptors . Although early studies documented potentiation of VACCs by ATP, for instance in rat cardiac myocytes (Bjornsson et al. 1989; Scamps and Vassort 1994) , in hippocampal neurons (Dave and Mogul 1996) , or in in vivo studies in the striatum (Zhang et al. 1995) , in most of these cases, neither the involvement of P2Y receptor subtype(s) nor the role of G proteins and their signalling mechanisms in the interaction was unambiguously demonstrated. In guinea-pig terminal mesenteric arterioles, P2Y agonists have been reported to be able to both potentiate (via P2Y 11 activation: G s /adenylate cyclase/ cAMP/protein kinase A) and inhibit (via P2Y 1 activation: G q/11 /PLCβ/PKC) a specific high-voltage-activated calcium channel (Morita et al. 2002) . Release of Ca 2+ from intracellular stores caused by P2Y receptor activation may result in Ca 2+ entry through store-operated channels (e.g. Rubini et al. 2006) , but the detailed discussion of this rather indirect interaction would exceed the proportions of this review.
Nevertheless, usually P2Y receptor activation leads to the inhibition of VACCs. Table 1 summarizes the available data concerning this issue. Analysis of the inhibitory mechanism revealed that P2Y receptor-dependent activation of G proteins could lead to an inhibition of Ca 2+ currents via two different characteristic mechanisms. The modulation of L-type currents is, in most cases, mediated by diffusible second messengers and protein kinases linked to the α subunit of G proteins (Bean 1989; . In contrast, the inhibition of N-and P/Q-type channels is mostly (but not always) independent of diffusible factors. In these cases, a membrane-delimited mechanism, i. e. a direct interaction of G protein βγ subunits with VACCs, is responsible for the effect. This βγ subunit-mediated inhibition is voltage dependent because the binding of βγ subunits to calcium channels is reduced by depolarisation (during high-frequency bursts of action-potential-like waveforms). The most likely consequence of the βγ subunit binding to the channel is that it shifts the channels from "willing" to "reluctant" gating states, slows activation and reduces the peak amplitude of whole-cell calcium current. However, even in case of this latter mechanism, on certain occasions, soluble factors were also required for the inhibitory effect (Filippov et al. 2003) .
Interestingly, a recent study on HEK293 cells revealed that using low-frequency trains of action-potential-like waveforms, activation of endogenous G proteins could reduce the inactivation of N-type calcium channel currents as well (McDavid and Currie 2006) . Such a decrease in the inactivation of calcium current was produced by P2Y receptors in adrenal chromaffin cells. The effect was dependent on the βγ subunit. Interaction of P2Y receptors with potassium channels Several lines of evidence support that P2Y receptors interact with some representatives of the large and diversified family of potassium channels. Table 2 summarizes our present knowledge on the purinergic modulation of M-type potassium currents (I M ; the channel responsible for this current is also denoted as KCNQ2+3 or K v 7.2 and 7.3; Robbins 2001; Jentsch 2000) . These channels conduct the primary K + current activated at voltages near the threshold for action-potential initiation; their closure facilitates membrane depolarisation and fast excitatory transmission. Agonists of various P2Y receptors, as of other GPCRs, have been shown to inhibit the M-type potassium current. The mechanism of the inhibition by P2Y receptors involves PTX-resistant G proteins; recent data indicated that PLCdependent PIP 2 depletion in the membrane (see above) might be an essential step in the P2Y-receptor-mediated inhibition of M-type currents. However, other mechanisms such as the classical PLC-IP 3 -Ca 2+ signalling could also be involved. Interestingly, the age dependence of the inhibitory action on M-type currents was also observed (for references, see Table 2 ).
In contrast to the M current, in case of another classical voltage-gated potassium-current type, the I K current, the experimental data are puzzling. The delayed rectifier I K potassium current is the major determinant of the ventricular repolarisation, but the channel subunits are localized not exclusively in the heart (Kurokawa et al. 2001; Thomas et al. 2006) . Two components of I K , a rapid (I Kr : hERG, KCNH2 or K v 11.1) and a slow (I Ks : KvLQT or K v 7.1) have been identified. Sporadical reports on the modulation (both enhancement and inhibition) of these channels via various signalling mechanisms indicate that they might also be targets of purinergic receptors. This possibility should be kept in mind in case of pharmacological interventions with P2Y receptor ligands (for details and references, see Table 2 .).
The G protein-coupled inwardly rectifying (GIRK or K ir ) potassium channels contribute to the regulation of mem- Guinea-pig atrial myocytes Matsuura and Ehara 1997; Ding et al 2004 brane excitability in muscle and nerve (Sadja et al. 2003; Kobayashi and Ikeda 2006) . P2Y receptor agonists may exert a biphasic action on these channels (Table 3) . Various P2Y receptor agonists initially cause a rapid activation, which may be followed by a slow, accelerated inactivation. The activation is probably mediated by a membranedelimited mechanism, i.e. the direct interaction of the βγ-subunit of a PTX-sensitive G protein with the channel. If a slower inactivation also occurs, the underlying mechanism involves PTX-resistant G proteins and cytosolic second messengers (for more details and references, see Table 3 ). Several reports demonstrated that P2Y receptor agonists activate outwardly rectifying potassium channels in neurons of various brain regions. This interaction seems to involve a PTX-resistant G protein. Either its βγ-subunit interacts with the channel by a membrane-delimited mechanism, or its α subunit initiates a signalling cascade involving cytoplasmic second messengers. More recently, a similar interaction was observed in microglial cells as well (for more details and references, see Table 3 ).
GPCRs can release Ca 2+ from internal stores. Therefore, an obvious possibility is that they may activate Ca 2+ -dependent potassium channels. Indeed, such effects were observed in various cell types, for example in rat hepatocytes, human coronary artery smooth muscle cells, isolated rat osteoclasts, murine colonic smooth muscle cells, human retinal Müller glial cells, etc. (e.g. Bringmann et al. 2002; Koh et al. 1997; Strobaek et al. 1996; Weidema et al. 1997; Yamashita et al. 1996) . The activation might involve all known K Ca channel types: the big, the intermediate and the small conductance channels. However, as this kind of interaction is also quite indirect, we do not specify it further.
A further example of a P2Y receptor-K + channel interaction was presented in guinea-pig ventricular myocytes (Oketani et al. 2002) . P2Y receptor ligands, in a rank order of potency: ATP > β,γ-meATP = ADP > AMP Outward rectifier Activation P2Y 1 and/or P2Y 2 / P2Y 4
Not specified Mice microglial cells Boucsein et al. 2003 inhibited ATP-sensitive potassium channels. Most likely, the PLC-induced PIP 2 -depletion mechanism was responsible for this effect.
Interaction of P2Y receptors with chloride channels The diversified superfamily of chloride channels is essential, e.g. for volume homeostasis, the transepithelial transport of salt and water as well as the modulation of electrical excitability in neurons. In addition to the ligand-gated GABA A and glycine channels, the chloride channel family comprises the voltage-dependent chloride channels (ClCs), the Ca 2+ -activated chloride channels (CaCCs) channels, and the cAMP-activated CFTR (Aleksandrov et al. 2007; Matulef and Maduke 2007) . Furthermore, a subset of chloride channels can also be activated by an increase in cell volume.
Numerous studies demonstrated an interaction between P2Y (or P2X) purinergic receptors and chloride channels, mostly in epithelia, but in other tissues as well. Earlier studies have shown that ATP or UTP led to an increase in Cl − secretion in human airway epithelial cells (Knowles et al. 1991; Mason et al. 1991) . The role of UTP-sensitive P2Y receptors in the activation of CaCCs was later confirmed in various tissues, for instance in airway epithelial cells (Hwang et al. 1996) , coronary artery smooth muscle cells (Strobaek et al. 1996) , renal collecting ducts (Cuffe et al. 2000) and pancreatic epithelial cells (Galietta et al. 1994) . It was revealed later that probably the G q proteincoupled P2Y 2 receptor, via PLC-IP 3 -dependent increase of intracellular Ca 2+ concentration, is mostly responsible for the activation of the CaCC channels. However, while the nucleotide-stimulated chloride secretion in the airways was almost entirely abolished in P2Y À=À 2 mice, the nucleotide effect was maintained completely in the jejunum and partially in the gallbladder (Cressman et al. 1999) . P2Y 4 receptors have been implicated in the stimulation of chloride secretion in these tissues (Ghanem et al. 2005; Robaye et al. 2003) . Furthermore, the P2Y 6 receptor has also been suggested to participate in the activation of CaCCs, for instance in mouse and human airway cells , and in human and mouse gallbladder epithelium (Lazarowski et al. 2001 ). In contrast, both an unknown UTP-sensitive receptor-type (or a heterodimer) and the P2Y 11 receptor have been suggested to be involved in the activation of CaCCs in rat pulmonary artery smooth muscle cells (Chootip et al. 2005) .
The stimulatory effect of P2Y 2 and P2Y 6 receptors on CaCCs via a PTX-resistant G protein was confirmed in the heterologous expression system of Xenopus oocytes (Mosbacher et al. 1998) . In Xenopus oocytes, however, besides the P2Y 6 , the P2Y 1 receptor also activated the CaCCs (Kottgen et al. 2003) .
The CFTR channel has a peculiar relation to purinergic transmission. It has repeatedly been discussed that this channel might be involved in the release of ATP from various cells (Schwiebert et al. 1995; Schwiebert and Zsembery 2003) . Extracellular nucleotides in turn seem to modulate the CFTR channel. In several cases, nucleotides, besides the activation of a transient chloride current (CaCC), also activated a more sustained one (CFTR). However, the experimental data are equivocal in this respect: both inhibition and activation via different receptor types involving both cAMP-dependent and cAMP-independent pathways have been observed.
Both the P2Y 1 receptor and CFTR can bind PDZ domain-containing proteins. These proteins may act as scaffolds favouring an interaction between P2Y 1 and CFTR in membrane microdomains (Fam et al. 2005; Hall et al. 1998) . Indeed, in X. laevis nephron A6 cells, P2Y 1 receptors activated CFTR via the PLC-IP 3 -Ca 2+ -PKC pathway (Guerra et al. 2004 ). Activation of this pathway potentiated the cAMP-protein kinase A pathway which then activated CFTR via A-kinase-anchoring proteins. CFTR association with the PDZ domain of NHERF-2 was critical for the interaction. In human airway epithelial cells, stimulation of P2Y 1 receptors on the apical side also activated CFTR conductances via the adenylate cyclase-cAMP pathway (Son et al. 2004 ). Interestingly, a Ca 2+ -activated potassium channel on the basolateral membrane activated by a P2Y 1 receptor and coupled to the PLC-DAG-Ca 2+ pathway was necessary to maintain this effect on CFTR. In contrast, in a heterologous expression system (Chinese hamster ovary cells), P2Y 1 activation did not affect CFTR function (Marcet et al. 2004 ). However, CFTR expression shifted P2Y 1 coupling: P2Y 1 receptors, which are known to couple primarily to G q proteins, coupled to G i/o proteins in the presence of CFTR.
The data regarding the influence of P2Y 2 receptors on CFTR are also somewhat incongruous. P2Y 2 receptors have been shown to activate CFTR in human nasal epithelial cells, via G q -protein-PLC-DAG-PKC signalling (Paradiso et al. 2001) . Previously, Hwang et al. (1996) also reported Ca-independent activation of CFTR currents in rat airway cells via a UTP-sensitive receptor, but neither the receptor subtype nor the signalling was elucidated. Furthermore, a P2Y 2 -mediated activation of CFTR was observed in mouse ventricular myocytes via G q/11 -PLC-PKC signalling (Yamamoto-Mizuma et al. 2004; Yamamoto et al. 2007) , and a UTP-sensitive receptor has been reported to activate CFTR via PKC-dependent phosphorylation of the channel protein in porcine endometrial gland epithelial cells (Palmer et al. 2006) . In contrast, in a heterologous model (CFTRexpressing Chinese hamster ovary cells), CFTR was repressed by P2Y 2 receptors via G q -PLC-Ca 2+ signal (Marcet et al. 2003; Marcet et al 2004) .
P2Y 4 receptors might be involved in the activation of CFTR in the jejunum (Lazarowski et al. 2001 ), while P2Y 6 receptors activated CFTR in mouse and human airway cells via a cAMP-dependent mechanism , as well as in colonic epithelial cells and Xenopus oocytes via a Ca 2+ and cAMP-dependent mechanism (Kottgen et al. 2003 ). An early study described P2X receptor-mediated, cAMP and Ca-independent potentiation of CFTR in mouse mammary carcinoma cells transfected with human CFTR (Cantiello et al. 1994 ). ATP and UTP have been shown to activate another chloride current type, the outwardly rectifying chloride current, in human and rat airway epithelial cells (Schwiebert et al. 1995; Hwang et al. 1996) . ATP released due to cellular swelling may act in an autocrine manner on P2Y receptors to potentiate swelling-activated Cl − currents in rat hepatoma cells (Wang et al. 1996) or in human and rat biliary epithelial cells (Roman et al. 1999 ). More recently, this mechanism was observed in rat astrocytes as well (Darby et al. 2003) . NMDA receptors appear to be situated at the pyramidal neurons, whereas P2Y 4 receptors may be situated at neighbouring astrocytes (see Wirkner et al. 2007 ). Cells were held at −80 mV, and substances were applied changing the superfusion medium by three-way taps. NMDA (30 μM) was applied three times (T 1 -T 3 ) for 1.5 min every 10 min. Current responses were reproducible at T 2 and T 3 under these conditions. ATP (300 μM), UDP (100 μM), UTP (100 μM) and ADP-β-S (100 μM) were applied 5 min before and during T 3 . PPADS (30 μM) was superfused at least 15 min before T 1 and throughout. The genetic deletion of P2Y 2 receptors appeared to greatly increase the potentiation of NMDA currents by both ATP and UTP (d). This potentiation was, however, absent after the deletion of both P2Y 1 and P2Y 2 receptors or after the deletion of P2Y 1 receptors only (c, e). Hence, P2Y 2 receptors may exert a negative control on the agonistic effects of nucleotides on NMDA currents, in a manner requiring the presence of P2Y 1 receptors. Asterisk P<0.05; statistically significant difference from controls at T 2 . Pound sign P<0.05; statistically significant difference from the effect of ATP or UTP alone. This figure was constructed by adding new data to the modified Fig. 6 of Wirkner et al. (2007) Interaction of P2Y receptors with ionotropic glutamate receptors In the last decade, our laboratory explored and elucidated a complex interaction between multiple P2Y receptor subtypes and ionotropic glutamate NMDA receptors in the prefrontal cortex (PFC) of rodents involving both direct and indirect mechanisms. First, we demonstrated that ATP, via an ATP-and UTP-sensitive P2Y receptor, potentiated the conductance of NMDA receptors at a subpopulation of layer V PFC pyramidal neurons, although the respective P2 receptor agonists did not cause current responses when applied alone ( Fig. 1; Wirkner et al. 2002, 2007) . The blockade of this effect by substances known to interact with gliotransmitter release suggested that an astrocytic signalling molecule may participate. Since mGluR group I agonists and antagonists imitated and blocked the effect of ATP, respectively, it has been suggested that the signalling molecule is probably glutamate. The use of pharmacological antagonists (suramin, PPADS, MRS 2179) and knockout mice (P2Y Subsequently, we clarified that activation of ADP-β-Ssensitive P2Y receptors inhibited rather than potentiated the NMDA-responses in the PFC (Fig. 2) . ADP-β-S appeared to activate P2Y 1 receptors, since its effect was abolished by the preferential antagonist PPADS and the highly selective antagonist MRS 2179. While the facilitatory effect of the UTP-sensitive receptor involved the activation of a G protein and subsequently PKC or CaMKII, the inhibitory P2Y 1 receptor-mediated ADP-β-S effect was suggested to occur by a membrane-delimited, direct cross-talk with NMDA receptors without activation of second-messenger systems (Luthardt et al. 2003) . Further, our data indicated that P2Y 1 receptors inhibited not only the amplitude of synaptic currents but also the synaptic plasticity of glutamatergic neurotransmission in the rat prefrontal cortex (Guzman et al. 2005) .
Double immunofluorescence experiments with confocal laser microscopy and co-immunoprecipitation studies revealed co-localization between the P2Y 4 and NMDAR1 receptors at the membrane level in both homologous . . Both receptors appear to be situated at the same pyramidal neuron (see Luthardt et al. 2003) . Cells were held at −70 mV, and all substances were locally superfused by means of a rapid application system. NMDA (300 μM) was applied every 1 min for 1 s and nine times in a total. ADP-β-S (100 μM) was superfused for 3 min, during the fourth, fifth and sixth applications of NMDA. a Stable currents induced by NMDA. b The same NMDA currents evoked before (Control), during and after superfusion with 100 μM ADP-β-S (Washout). c Mean± SEM of 14 experiments similar to those shown in (b). The currents were normalized with respect to the last control (pre-drug) value immediately before the application of ADP-β-S. Single asterisk P< 0.05; significant differences from the third control response to NMDA. Double asterisk P<0.05; significant differences from the preceding column. d Concentration-dependence of the inhibitory effect of ADP-β-S on the NMDA-induced inward current. The same concentration of NMDA (300 μM) was applied every 1 min for 1 s and 8-16 times in total. Increasing concentrations of ADP-β-S (1-1,000 μM) were superfused for 2 min each. Every point represents the mean±SEM of three to eight measurements. Single asterisk P<0.05; significant difference from control. This figure was constructed by modifying Figs. 6 and 7 of Luthardt et al. (2003) (cerebellar granule neurons) and heterologous (HEK293 cells) systems and suggested a molecular interplay between these receptors (Cavaliere et al. 2004 ). This UTP-sensitive receptor type was a possible candidate to mediate the facilitatory P2Y-NMDA interaction in our experiments as well.
Interaction of P2Y receptors with Cys-loop receptors Besides the known presynaptic effect of P2X and P2Y receptors controlling neurotransmitter release including that of GABA (Illes and Ribeiro 2004) , a recent study reported that P2Y 1 receptor activation in cerebellar Purkinje cells postsynaptically increase the co-localized GABA A receptorsensitivity through G protein-coupled intracellular Ca 2+ elevation (Saitow et al. 2005) .
Interaction of P2Y receptors with transient receptor potential channels The transient receptor potential vanilloid 1 (TRPV1) or VR1 receptor is a non-selective ligand-gated cation channel involved in the sensation of pain; it may be activated by heat, low pH and capsaicin, the ingredient of hot chili peppers. ATP has been found to potentiate capsaicin-or H + -evoked currents and to lower the temperature threshold for heat activation of TRPV1 channels in rat DRG neurons and HEK293 cells (Tominaga et al. 2001 ). P2Y 1 receptors via G q/11 -protein-PLC-IP 3 -DAG-PKC have been suggested to be involved in this interaction. Then, the functional interaction between ATP and TRPV1 was confirmed at the behavioural level, i.e. ATP-induced thermal hyperalgesia was abolished in mice lacking TRPV1 receptors. However, experiments with P2Y À=À 1 mice revealed that this receptor type is probably not involved in the potentiation of TRPV1 currents (Moriyama et al. 2003) . Electrophysiological experiments in mouse DRG neurons also argued for the involvement of P2Y 2 rather than P2Y 1 receptors. Furthermore, co-expression of TRPV1 with P2Y 2 , but not with P2Y 1 receptors, was demonstrated in the rat DRG.
Furthermore, recent data indicate that electrically evoked neuronal excitation in the spinal dorsal horn was prevented by TRPV1 activation (Kusudo et al. 2006 ). This inhibitory action was antagonized by P2Y receptor antagonists and was facilitated by P2Y agonists, respectively.
Interaction of P2Y receptors with other ion channels A slowly activating T in inward current was measured after the activation of various G q -coupled receptors, including P2Y 1 , when expressed in Xenopus oocytes (O'Grady et al. 1996) . The activation of the current requires G q α subunits, Ca 2+ and strong hyperpolarization of the membrane. The molecular identity of the T in channel is obscure. P2Y 1 , P2Y 2 , P2Y 6 and P2Y 11 but not P2Y 4 receptors have been reported to modulate the voltage sensitivity and inactivation gating of this ion channel . It was hypothesized that the modulation occurs via direct protein-protein interactions involving C-terminal domain sequence motifs distinct from the PDZ-binding motif of these P2Y receptors. P2Y 1 and P2Y 2 receptor-activation via IP 3 -Ca 2+ signalling has been shown to open the gap-junction protein pannexin-1 channels in Xenopus oocyte cell membranes (Locovei et al. 2006) . It was suggested that these pores might be involved in ATP release, as well as calcium-wave initiation and propagation.
Conclusions
The presently known seven subtypes of P2X and eight subtypes of P2Y receptors cannot explain the huge diversity of cellular effects induced by extracellular nucleotides. There are a number of possible explanations to dissolve this riddle.
(1) Further subtypes of P2 receptors still escaped discovery. A series of orphan GPCRs (i.e. cloned receptors available in the public database for which a natural ligand has not yet been identified) share significant sequence identity with the genuine P2Y receptors . Some of these have recently been deorphanized and found to be nucleotide sensitive (Ciana et al. 2006) , while other ones, in spite of the original expectations did not respond to these agonists (Inbe et al. 2004; Abbracchio et al. 2006) . (2) P2X receptors occur as heteromeric compositions of various subunits and, in addition, may physically associate with other ligand-gated cationic or anionic channels. The usual consequences of these alterations are modified agonist/antagonist selectivities, changes in activation/desensitization properties and occlusion following co-activation of the physically associated receptors. (3) P2Y receptors may constitute homo-or heterooligomeric complexes resulting, e.g., in hybrid structures combining the binding sites of one receptor with the signalling pathways of the other. (4) P2Y receptors may modulate the activation, desensitization and ion selectivity of P2X receptors as well as their trafficiking into and out of the cellular membrane. Changes in the trafficking properties necessarily lead to the up-or down-regulation of receptors and, therefore, modifications in agonist sensitivity. (5) Eventually, P2Y receptors may interact with the transduction mechanisms of other P2Y or P2X receptors at multiple steps of these reaction chains. Hence, we are in the middle of the tedious procedure to sort out the numerous possibilities enabling us to pharmacologically modify purine/pyrimidine effects in the human organism and to avoid possible side effects originating from the extreme complexity of the purinergic system (Volonte et al. 2006 ). 
